April 3rd Shanghai and Shenzhen Stock Exchange Limit-Up Analysis: JinYao Pharmaceutical Hits 6 Consecutive Limit-Ups

MaticHoleFiller · 2026-04-04T02:35:48+00:00

Special Topic: The current point may be the mid-term low for A-shares; the decline presents a good opportunity for allocation

MaticHoleFiller

2026-04-04 02:35:48

Topic: Right now—or possibly the midpoint low point in China’s A-share market. Pullbacks create an opportunity for allocation

            Hot Sections
            
            Watchlist
            Data Center
            Market Quotes Center
            Capital Flow Monitor
            Paper Trading
        

        Client

When it comes to stock trading, rely on the analyst research reports from iFLYTEK’s Golden Qilin—authoritative, professional, timely, and comprehensive. It helps you uncover promising theme opportunities!

The Shanghai Composite Index fell by 1% on declining volume and slipped below 3,900 points. Across the entire market, more than 4,700 stocks declined, and trading value was under 1.7 trillion. The optical communication concept strengthened against the trend. Tianshui Pharmaceutical Industry hit six consecutive daily limit-ups—one chart to understand >>

A massive amount of information and precise analysis—right on the Sina Finance app

Responsible Editor: Guo Yutong

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.